Abstract:Abstract Skin cancer is the most common type of cancer in the US, with an estimated 3.5 million cases diagnosed each year. Exposure to ultraviolet (UV) radiation, namely UVA (320-400 nm) and UVB (290-320 nm), is the major risk factor for the development of skin cancer. UVA is 20-fold more abundant in sunlight than UVB and is the major component of tanning beds. However, the mechanism of UVA's contribution to skin cancer remains unclear. One putative effector of UVA in skin cancer is p62, a selective autophagy cargo protein and substrate. We have found that UVA upregulates p62 expression, independent of autophagy, by inducing transcription of p62. p62 is upregulated in many types of cancer, including squamous cell carcinoma (SCC) and melanoma, and can facilitate the activation of a number of pathways to promote cell proliferation, invasion, inflammation, and survival. We have previously shown that p62 stabilizes Twist1 to promote invasion and proliferation, indicating p62 can function independent of autophagy to promote tumor progression. However, the function of p62 in UVA-induced tumor progression is unknown. Using a candidate gene approach, we identified a novel interaction between p62 and cyclooxygenase-2 (COX-2), which suggests a putative function for p62 in UVA-induced skin cancer. COX-2 is a prostaglandin synthase often overexpressed in cancer, where it correlates with poor prognosis. COX-2 promotes cell proliferation and survival, and inhibition of COX-2 prevents skin cancer development. COX-2 protein expression is induced concomitantly with p62 in response to UVA and knockdown of p62 prevents induction of COX-2 by UVA. As COX-2 transcription is not induced by UVA in skin cancer cells along with p62, we assessed a possible protein-level regulatory mechanism. Co-immunoprecipitation of endogenous p62 and COX-2 in skin cancer cells reveals a novel physical interaction between these proteins. Therefore, we hypothesize that p62 transcription is induced by UVA to promote stability of cyclooxygenase-2 (COX-2) and consequently, tumor progression. This project aims to further understand how UVA regulates p62 and thus COX-2 availability, and the functional significance for skin tumor progression. As both p62 and COX-2 are critical for skin tumor progression, understanding the link between these proteins will unravel a signaling axis central to skin cancer progression. Citation Format: Ashley Sample, Lei Qiang, Baozhong Zhao, Yu-Ying He. The role of p62-dependent regulation of COX-2 in UVA response and skin tumor progression. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 4060.

P62 Functions As an Oncogene in Colorectal Cancer Through Inhibiting Apoptosis and Promoting Cell Proliferation by Interacting with the Vitamin D Receptor.

XIAP Facilitates Breast and Colon Carcinoma Growth Via Promotion of P62 Depletion Through Ubiquitination-Dependent Proteasomal Degradation

P62 Promotes Proliferation, Apoptosis‑resistance and Invasion of Prostate Cancer Cells Through the Keap1/Nrf2/ARE Axis

p62 Promotes Malignancy of Hepatocellular Carcinoma by Regulating the Secretion of Exosomes and the Localization of beta-Catenin

Upregulation of CPE promotes cell proliferation and tumorigenicity in colorectal cancer

Wd40 Repeat-Containing 62 Overexpression As A Novel Indicator of Poor Prognosis for Human Gastric Cancer

Downregulation of ZNF365 by Methylation Predicts Poor Prognosis in Patients with Colorectal Cancer by Decreasing Phospho-P53 (ser15) Expression

VPS34 Stimulation of P62 Phosphorylation for Cancer Progression

SQSTM1/p62 promotes the progression of gastric cancer through epithelial-mesenchymal transition

The Role of C2orf68 and PI3K/Akt/mTOR Pathway in Human Colorectal Cancer

p62 as a therapeutic target for tumor

Abstract 4060: the Role of P62-Dependent Regulation of COX-2 in UVA Response and Skin Tumor Progression

P62 Promotes Bladder Cancer Cell Growth by Activating KEAP1/NRF2‐dependent Antioxidative Response

p62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA

P62/sqstm1 As an Oncotarget Mediates Cisplatin Resistance Through Activating RIP1‐NF‐κB Pathway in Human Ovarian Cancer Cells

p62 Promotes the Mitochondrial Localization of p53 through Its UBA Domain and Participates in Regulating the Sensitivity of Ovarian Cancer Cells to Cisplatin

P62 Acts As an Oncogene and is Targeted by Mir-124-3p in Glioma

DDX54 Plays a Cancerous Role Through Activating P65 and AKT Signaling Pathway in Colorectal Cancer

Sirt1 deacetylates and stabilizes p62 to promote hepato-carcinogenesis

A Crucial Interaction of p62 and Nrf2 in Mediating Metastasis of Esophageal Squamous Cell Cancer

Insight into the Role of P62 in the Cisplatin Resistant Mechanisms of Ovarian Cancer